Por favor, use este identificador para citar o enlazar este ítem:
https://doi.org/10.1002/jcb.22656
Twittear
Título: | Mechanism of Dihydrofolate Reductase Downregulation in Melanoma by 3-O-(3,4,5-Trimethoxybenzoyl)-(-)-Epicatechin |
Fecha de publicación: | 1-jun-2010 |
Editorial: | WILEY |
Cita bibliográfica: | Journal of Cellular Biochemistry Volume 110, Issue 6 pp. 1399-1409 |
ISSN: | Print: 0730-2312 Electronic:1097-4644 |
Materias relacionadas: | CDU::5 - Ciencias puras y naturales::57 - Biología::577 - Bioquímica. Biología molecular. Biofísica |
Palabras clave: | Melanoma Fólico, Ácido Gene expression Dihydrofolate reductase Hydrogen peroxide |
Resumen: | In our search to improve the stability and cellular absorption of tea polyphenols, we synthesized 3-O-(3,4,5-trimethoxybenzoyl)-(-)-epicatechin (TMECG), which showed high antiproliferative activity against melanoma. TMECG downregulates dihydrofolate reductase (DHFR) expression in melanoma cells and we detail the sequential mechanisms that result from this even. TMECG is specifically activated in melanoma cells to form a stable quinone methide (TMECG-QM). TMECG-QM has a dual action on these cells. First, it acts as a potent antifolate compound, disrupting folate metabolism and increasing intracellular oxidized folate coenzymes, such as dihydrofolate, which is a noncompetitive inhibitor of dihydropterine reductase, an enzyme essential for tetrahydrobiopterin (H4B) recycling. Such inhibition results in H4B deficiency, endothelial nitric oxide synthase (eNOS) uncoupling and superoxide production. Second, TMECG-QM acts as an efficient superoxide scavenger and promotes intra-cellular H2O2 accumulation. Here, we present evidence that TMECG markedly reduces melanoma H4B and NO bioavailability and that TMECG action is abolished by the eNOS inhibitor N-omega-nitro-L-arginine methyl ester or the H2O2 scavenger catalase, which strongly suggests H2O2-dependent DHFR downregulation. In addition, the data presented here indicate that the simultaneous targeting of important pathways for melanoma survival, such as the folate cycle, H4B recycling, and the eNOS reaction, could represent an attractive strategy for fighting this malignant skin pathology |
Autor/es principal/es: | Sánchez del Campo Ferrer, Luis Chazarra Parres, Soledad Montenegro Arce, María Fernanda Cabezas Herrera, Juan Rodríguez López, José Neptuno |
Facultad/Departamentos/Servicios: | Facultades, Departamentos, Servicios y Escuelas::Departamentos de la UMU::Bioquímica y Biología Molecular A |
URI: | http://hdl.handle.net/10201/137021 |
DOI: | https://doi.org/10.1002/jcb.22656 |
Tipo de documento: | info:eu-repo/semantics/article |
Número páginas / Extensión: | 32 |
Derechos: | info:eu-repo/semantics/openAccess Attribution-NonCommercial-NoDerivatives 4.0 Internacional |
Descripción: | © 2010. The authors. This is the peer reviewed version of the following article: [Sánchez-del-Campo L, Chazarra S, Montenegro MF, Cabezas-Herrera J, Rodríguez-López JN. Mechanism of dihydrofolate reductase downregulation in melanoma by 3-O-(3,4,5-trimethoxybenzoyl)-(-)-epicatechin. J Cell Biochem. 2010 Aug 15;110(6):1399-409, which has been published in final form at https://doi.org/10.1002/jcb.22656 |
Aparece en las colecciones: | Artículos: Bioquímica y Biología Molecular "A" |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
J cell biochem 2010.pdf | 694,53 kB | Adobe PDF | Visualizar/Abrir |
Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons